Literature DB >> 26004032

Emerging intracellular receptors for hemorrhagic fever viruses.

Lucas T Jae1, Thijn R Brummelkamp2.   

Abstract

Ebola virus and Lassa virus belong to different virus families that can cause viral hemorrhagic fever, a life-threatening disease in humans with limited treatment options. To infect a target cell, Ebola and Lassa viruses engage receptors at the cell surface and are subsequently shuttled into the endosomal compartment. Upon arrival in late endosomes/lysosomes, the viruses trigger membrane fusion to release their genome into the cytoplasm. Although contact sites at the cell surface were recognized for Ebola virus and Lassa virus, it was postulated that Ebola virus requires a critical receptor inside the cell. Recent screens for host factors identified such internal receptors for both viruses: Niemann-Pick disease type C1 protein (NPC1) for Ebola virus and lysosome-associated membrane protein 1 (LAMP1) for Lassa virus. A cellular trigger is needed to permit binding of the viral envelope protein to these intracellular receptors. This 'receptor switch' represents a previously unnoticed step in virus entry with implications for host-pathogen interactions and viral tropism.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ebola virus; LAMP1; Lassa virus; NPC1; fusion; internal/intracellular receptor

Mesh:

Substances:

Year:  2015        PMID: 26004032     DOI: 10.1016/j.tim.2015.04.006

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  23 in total

1.  Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.

Authors:  Stephen J Capuzzi; Wei Sun; Eugene N Muratov; Carles Martínez-Romero; Shihua He; Wenjun Zhu; Hao Li; Gregory Tawa; Ethan G Fisher; Miao Xu; Paul Shinn; Xiangguo Qiu; Adolfo García-Sastre; Wei Zheng; Alexander Tropsha
Journal:  J Med Chem       Date:  2018-04-17       Impact factor: 7.446

Review 2.  Lassa Virus Cell Entry Reveals New Aspects of Virus-Host Cell Interaction.

Authors:  Giulia Torriani; Clara Galan-Navarro; Stefan Kunz
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

3.  Synergistic drug combination effectively blocks Ebola virus infection.

Authors:  Wei Sun; Shihua He; Carles Martínez-Romero; Jennifer Kouznetsova; Gregory Tawa; Miao Xu; Paul Shinn; Ethan Fisher; Yan Long; Omid Motabar; Shu Yang; Philip E Sanderson; Peter R Williamson; Adolfo García-Sastre; Xiangguo Qiu; Wei Zheng
Journal:  Antiviral Res       Date:  2016-11-24       Impact factor: 5.970

4.  NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry.

Authors:  Matthijs Raaben; Lucas T Jae; Andrew S Herbert; Ana I Kuehne; Sarah H Stubbs; Yi-Ying Chou; Vincent A Blomen; Tomas Kirchhausen; John M Dye; Thijn R Brummelkamp; Sean P Whelan
Journal:  Cell Host Microbe       Date:  2017-11-08       Impact factor: 21.023

5.  The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.

Authors:  Yu-Jin Kim; Beatrice Cubitt; Emily Chen; Mitchell V Hull; Arnab K Chatterjee; Yingyun Cai; Jens H Kuhn; Juan C de la Torre
Journal:  Antiviral Res       Date:  2019-07-11       Impact factor: 5.970

6.  Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.

Authors:  C E Hulseberg; L Fénéant; K M Szymańska-de Wijs; N P Kessler; E A Nelson; C J Shoemaker; C S Schmaljohn; S J Polyak; J M White
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

7.  The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses.

Authors:  Eve-Isabelle Pécheur; Viktoriya Borisevich; Peter Halfmann; John D Morrey; Donald F Smee; Mark Prichard; Chad E Mire; Yoshihiro Kawaoka; Thomas W Geisbert; Stephen J Polyak
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

8.  Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.

Authors:  Joel Oppliger; Giulia Torriani; Antonio Herrador; Stefan Kunz
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

9.  Epistastic Interactions within the Junín Virus Envelope Glycoprotein Complex Provide an Evolutionary Barrier to Reversion in the Live-Attenuated Candid#1 Vaccine.

Authors:  Joanne York; Jack H Nunberg
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

10.  Secretome Screening Reveals Fibroblast Growth Factors as Novel Inhibitors of Viral Replication.

Authors:  Saskia D van Asten; Matthijs Raaben; Benjamin Nota; Robbert M Spaapen
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.